Marketing authorization holder for other medicinal products

We are expanding our range of medicines. Paesel + Lorei has been the marketing authorization holder for the Impavido 10 mg / 50 mg capsules product since June 22nd, 2016.

The medicine is used against the tropical disease leishmaniasis.